Stockreport

bluebird bio Reports First Quarter 2018 Financial Results and Highlights Operational Progress

bluebird bio, Inc.  (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
PDF – Completed Northstar study of LentiGlobin in transfusion dependent ß-thalassemia (TDT) – – Entered into co-development and co-promotion agreemen [Read more]